-
Learn how ZOMETA (zoledronic acid) helps prevent skeletal-related events (SREs) in patients with advanced malignancies involving bone metastases.
skeletal related events 
www.zometa.com - 2009-02-07
-
The InterventionZ program is designed for oncology and urology nurses to champion the cause of optimal care in the treatment of bone metastases.
bone health training  interventionz 
www.interventionz.com - 2009-02-06
-
China leading mamufacturer and supplier for Topiramate CAS:97240-79-4; Nefiracetam CAS:77191-36-7; Alendronate sodium CAS:121268-17-5; Etidronate disodium ...
118072-93-8  121268-17-5  55-98-1  57149-07-2  63245-28-3  7414-83-7  77191-36-7  89-25-8  95635-55-5  97240-79-4  Edaravone  Etidronate disodium  Etifenin  Nefiracetam 
www.mxmcpu.com - 2009-02-10
-
Reclast (zoledronic acid, sometimes called zoledronate) is in a group of medicines called bisphosphonates. It inhibits the release of calcium from bones.
zoledronate 
www.reclast.net - 2009-04-03
-
producer of API and its intermediates such as Tranexamic Acid;FaropenemSodium;Fluvoxamine Maleate;Fenoldopam Mesylate;Anastrozole;Atomoxetine/Tomoxetine;At ...
www.verychem.com - 2009-02-07
-
When cancer has spread to the bone, treatment with ZOMETA may reduce or delay bone complications. Learn more about how ZOMETA can help.
www.breastcancerandbones.com - 2009-02-12
-
Shanghai Kaile Industry Development Co., Ltd. Main Products:1,1'-Carbonyldiimidazole (CDI),N,N'-Disuccinimidyl carbonate (DSC),2-Ethyl-4-Methylimidazole,1- ...
1-Acetylimidazole-2466-76-4  1-Butylimidazole-4316-42-1  1-Ethylimidazole-7089-07-9  1-Methylimidazole-616-47-7  2-diaminobenzene  2-propyl-1H-imidazole-4  4-Bromo-1  4-hydroxyquinoline-611-36-9  4-Methyl-4-imidazolin-2-one  5-dicarboxy acid  5-dicarboxy acid diethyl ester  Disuccinimidyl  Imidazole-288-32-4  pyrrolidinone  Tiludronic Acid 
www.klpharm.com - 2009-02-04
-
How to register for Zometa (zoledronic acid) Information: breast cancer, prostate cancer, lung cancer, multiple myeloma, and bone metastases.
www.myzometa.com - 2009-04-02
|
cancer
multiple myeloma
bone metastases
zometa
breast cancer
novartis
fosamax
aredia
lymphoma
|
|